Related Experiment Video

Updated: Jun 8, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Genetic instability influences drug response in cancer cells

G Damia1, M D'Incalci

  • 1Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156 Milan, Italy. giovanna.damia@marionegri.it

Current Drug Targets
|September 16, 2010
PubMed

Insights

Defects in DNA mismatch repair (MMR) cause cancer cell heterogeneity and affect treatment response. Understanding MMR status can guide personalized cancer therapy for better outcomes.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Cancer cell heterogeneity, linked to genomic instability and DNA mismatch repair (MMR) defects, limits curability of advanced cancers.
  • Microsatellite instability (MSI), a marker for MMR deficiency, correlates with mutations in cancer-related genes.
  • Lynch syndrome, an inherited MMR deficiency, increases the risk of colorectal, endometrial, and other cancers.

Purpose of the Study:

  • To review current knowledge on DNA mismatch repair (MMR) in cancer.
  • To explore the relationship between MMR status, microsatellite instability (MSI), and cancer predisposition.
  • To summarize the implications of MMR defects for anticancer drug sensitivity.

Main Methods:

  • Literature review of current knowledge on DNA mismatch repair (MMR).
  • Analysis of the association between microsatellite instability (MSI) and MMR gene mutations.
  • Evaluation of preclinical evidence on MMR deficiency and response to chemotherapy.

Main Results:

  • MMR defects contribute to cancer heterogeneity and MSI.
  • Germline MMR gene mutations define Lynch syndrome, a hereditary cancer predisposition.
  • MMR-deficient cells show resistance to certain chemotherapies (e.g., 5FU) but sensitivity to others (e.g., oxaliplatin, irinotecan).

Conclusions:

  • MMR status is a critical factor influencing cancer development and progression.
  • MMR deficiency is associated with specific cancer syndromes like Lynch syndrome.
  • Tailoring cancer therapy based on MMR status holds promise for improved treatment efficacy.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...